PPARG and cancer: Based on this alternative hypothesis, disrupting the FABP5-PPARγ-VEGF signalling axis and cutting off the alternative energy supply of the cancer cells, rather than blocking the last drop of androgen, should be the correct way to kill the AR-negative CRPC cells.